In the largest venture financing round this week, Varda Space Industries closed a $251 million financing round to help fund ...

Bayer has looked internally for a new chief medical officer, appointing Dr Christoph Koenen to the position in addition to ...

Pharmaceutical launch plans are often thoroughly researched, carefully costed, and internally aligned. The problem is that ...

The Global Benchmark for Efficient Drug Pricing (GLOBE) model aims to introduce the Trump administration's Most Favoured ...

Sanofi's long-running R&D alliance with Regeneron has gone up a gear with a partnership – worth up to $8 billion – that spans ...

Eli Lilly's bid to dominate the next generation of weight-loss therapies has been strengthened by data on a new combination ...

Frontiers Health 2026, strengthening a long-standing collaboration dedicated to advancing conversations around innovation in ...

The personalized cancer vaccine field has reached a defining milestone. With Moderna and Merck reporting positive initial ...

AbbVie's long-acting anti-IL-13 antibody zumilokibart – the main asset in its $10.9 billion takeover of Apogee Therapeutics – ...

The US regulatory agency has just started a priority review of Imfinzi (durvalumab), in combination with Pfizer and ...

Novartis has added a T-cell engager (TCE) developed by China's Abogen Biosciences for autoimmune disorders in a deal that ...

Patients in England and Wales with rare disease familial chylomicronaemia syndrome (FCS) will soon have a new treatment ...